1

PREVALENCE OF OVERWEIGHT IN COMPARISON TO WASTING, AMONG IRANIAN UNDER 5 YEAR- OLD CHILDREN IN URBAN AND RURAL
M. Abtahi, A. Houshiarrad, M. Abdollahi, B. Mohammadpour, A. Doustmohammadian, Iran

2

CHARACTERISTICS OF SUBJECTS WITH A HIGH WAIST CIRCUMFERENCE AND CARDIOMETABOLIC RISK FACTORS: THE 5A STUDY
C. Aguilar-Salinas,A. Avezum, E. Bruckert,  J. Chan,  A. Misra,  I. Raz,  A.M. Sharma, 

T. Van der Merwe, Mexico

3

OVERWEIGHT AND THE FREQUENCY OF HYPERTENSION AND TYPE 2 DIABETES, RELATIONSHIP WITH SMOKING AND PHYSICAL INACTIVITY
D. Alexander, D. Christine, L. Monika, Austria

4

INFLUENCE OF MEAN BLOOD GLUCOSE IN THE HEMOGLOBIN A1C PROFILE
B. Almeida,C. Botelho, I. Coelho, Portugal        

5

METABOLIC PARAMETERS OF ADIPOSE TISSUE IN OBESE ZUCKER RATS SUGGEST AN EXISTENCE OF DEFENSE MECHANISM AGAINST OBESITY
M. Baculikova, R. Fiala, A. Kebis, M. Kukan, S. Zorad, Slovakia

6

THE EFFECT OF POLYPHENOLS ON GLUCOSE METABOLISM AND IMMUNE MODULATION IN EXPERIMENTALLY – INDUCED DIABETES
M. Badescu, M. Groza, D. Tutunaru, C. Pohaci, M. Ciocoiu, Romania

7

THE EVIL QUADRANGLE-THE IMPACT OF BLOOD PRESSURE, OBESITY AND DENTAL ILL-HEALTH ON DIABETES
A. Baigi, B. Marklund, B. Mוnsson, E. Mוnsson, Sweden     

8

THE PREVALENCE OF THE METABOLIC SYNDROME AMONG HYPERTENSIVE PATIENTS IN A COMMUNITY PRACTICE IN ISRAEL
I. Bar-Or,H. Shapira, Israel          

9

INT-2 GENE AMPLIFICATION IN IRANIAN DIABETIC PATIENTS, A NOVEL INSIGHT INTO PATHOGENECITY AND MOLECULAR GENETICS OF DIABETES MELLITUS
S. Bidoki, M. Akbari, Z. Zahraei, P. Abdolmaleki, Iran        

10

GLP-1 ANALOG LIRAGLUTIDE IMPROVES GLYCEMIC CONTROL AND REDUCES WEIGHT IN PATIENTS ON METFORMIN AND ROSIGLITAZONE
L. Blonde, J. Gerich, J. Buse, A. Lewin, S. Schwartz, P. Raskin, P. Hale, M. Zdravkovic,

B. Zinman, USA   

11

BMI AND RISK OF ALL-CAUSE AND CARDIOVASCULAR MORTALITY AMONG HOSPITALIZED ELDERLY
M. Boaz,Y. Beloosesky, E. Grossman, A. Weiss, Israel        

12

CINNAMON TREATMENT AND DIABETES: A RANDOMIZED CLINICAL TRIAL
M. Boaz, S. Heller, Z. Matas, J. Weinstein, Israel   

13

IMPLEMENTATION OF STANDARDS OF MEDICAL CARE IN DIABETES IS ASSOCIATED WITH REDUCTION OF RANDOM SERUM GLUCOSE IN HOSPITALIZED DIABETIC PATIENTS
M. Boaz, Z. Landau, J. Wainstein, Israel

14

SEVERITY OF UREMIC PRURITUS AMONG DIABETIC VS. NON-DIABETIC MAINTENANCE HEMODIALYSIS PATIENTS
M. Boaz, Z. Katzir, L. Shtendik, J. Wainstein, Israel

15

PERIPHERAL ARTERIOPATIA IN HYPERTENSE AND HIS RELATION WITH ANTHROPOMETRIC INFORMATION OF CARDIOVASCULAR RISK
F. Bobe, M. Buil, G. Trubat, A. Allue, M. Bobe, A. Morro, M. Junc, M. Fernandez,

N. Nievas, M. Maxenchs, A. Alonso, R. Lopez De La Blanca, Spain

16

PERIPHERAL ARTERIOPATY (ARP) AND HIS RELATION WITH THE DIET AND THE QUALITY OF LIFE
F. Bobe,M. Buil, G. Trubat, A. Allue, A. Morro, A. Alonso, M. Maxenchs, M. Checa,

N. Nievas, M. Fernandez, R. Moreno, M. Bobe, Spain

17

PERIPHERAL ARTERIOPATY (ARP) IN PATIENTS WITH FACTORS OF CARDIOVASCULAR RISK (FRCV) AND HIS RELATION WITH THE RENAL DAMAGE
F. Bobe, M. Buil, G. Trubat, A. Allue, A. Morro, A. Alonso, M. Maxenchs, M. Checa,

N. Nievas, M. Fernandez, M. Junca, M. Bobe, Spain

18

RELATION BETWEEN OBESITY AND SEVERITY OF THE ARTERIAL HYPERTENSION
F. Bobe, M. Buil, G. Trubat, A. Allue, M. Bobe, A. Morro, M. Junc, N. Nievas, A. Alonso,

M. Maxenchs, M. Fernandez, R. Lopez, Spain

19

TRUE “SLOW CARBS” HAVE SIGNIFICANT EFFECTS ON PLASMA GLUCOSE AND INSULIN CHANGES, BUT MINOR EFFECTS ON SATIETY
H. Boers-De Bruijn, H. Peters, H. Hijden Van Der, P. Ravestein, E. Haddeman,

S. Wiseman, Netherlands

20

DOES OBESITY RELATED HYPERTENSION INFLUENCE ENDOTHELIAL PROGENITOR CELLS NUMBER?
P. Bogdanski, K. Musialik, E. Kasprzak-Miller, L. Kilinska, Poland

21

THE EFFECTIVENESS OF THE TEAM-BASED CARE IN THE MANAGEMENT OF DIABETES MELLITUS TYPE 2 IN THE COMMUNITY SETTING: A RANDOMIZED CONTROLLED TRIAL
M. Bongcayao, J. Isidro, S. Lavina, S. Wong, Philippines

22

INSULIN DETEMIR PLUS REPAGLINIDE IMPROVES GLYCAEMIC CONTROL IN

INSULIN-NAIVE ELDERLY PATIENTS WITH TYPE 2 DIABETES
J. Bregnhøj, A. Liebl, Germany

23

PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TREATED IN A TEACHING HOSPITAL IN AMSTERDAM: INTERIM ANALYSIS
C.J. Brouwer, T. Schreuder, L.M. Morsink, N. van Ooteghem, B.J.P. van Loon, Netherlands

24

AVERAGE VALUE OF THE GLOMERULAR FILTRATION RATE IN DIABETIC POPULATION ACCORDING TO THE EQUATION MDRD-4 AND COCKCROFT-GAULT
M. Buil-Arasanz, F. Bobe, A. Allue, G. Trubat, M. Maxenchs, M. Bobe, J. Segura, Spain

25

THE ANALYZE OF METABOLIC SYNDROME  ELEMENTS  AT THE PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
E. Caceaune, N. Caceaune, C. Ionescu-Tirgoviste, Romania

26

Comparison of body composition variables derived from bioelectrical impedance (BIA) and deuterium method
M.N. Campanelli Marcal Vieira, J. Pontes Monteiro, C.M. Mendes Resende, K. Pfrimer, F. Eulogio Martinez, J.S. Camelo Junior, Brazil

27

Changes in body composition, after weight-reduction program of a 6-month period in obese adolescents
M.N. Campanelli Marcal Vieira,C.M. Mendes Resende, J. Pontes Monteiro, H. Bettiol,

R. Borges Donego Toffano, Brazil

28

PLATELET GLYCOPROTEIN POLYMORPHISMS AND THE PRESENCE OF ISQUEMIC EVENTS IN DIABETES MELLITUS TYPE II
V. Carvalhais,L. Pina-Cabral, E. Ruivדes, F. Oliveira, B. Mesquita, M. Monteiro,

A. Almeida-Dias, B. Criado, Portugal

29

VARIOUS BLOOD PRESSURE CIRCADIAN RHYTHM AND CARDIOVASCULAR REMODELING IN GEORGIAN OBESE HYPERTENSIVE SUBJECTS
K. Chagunava, G. Lomtatidze, T. Kurtanidze, Georgia

30

CARDIOMETABOLIC RISK FACTORS IN SUBJECTS WITH HIGH WAIST CIRCUMFERENCE: PREVALENCE, THERAPY & CONTROL. THE 5A STUDY
J. Chan, C. Aguilar-Salinas, A. Avezum, E. Bruckert, , A. Misra, I. Raz, A. Sharma, T. Van Der Merwe, China

31

LONG-TERM ETHANOL FEEDING IMPAIRS RATS’ LIVER AND INFLUENCES GLYCOGEN AND GLYCOGEN SYNTHESE KINASE-3,GLUT4 ,AMP KINASE
S. Chen, J. Zhao, L. Gao,  China

32

METABOLIC SYNDROME AND THE RISK FOR CHRONIC KIDNEY DISEASE AMONG KOREAN WOMEN : HIGH BLOOD PRESSURE AND HYPERTRIGLYCERIDEMIA PLAY KEY ROLES
S. Cho,H. Park, Korea

33

GESTATIONAL WEIGHT GAIN BY BODY MASS AMONG U.S. WOMEN: FUELING FUTURE OBESITY GESTATIONAL WEIGHT GAIN
S. Chu, W. Callaghan, C. Bish, D. D'Angelo, USA

34

THE HEPATIC ANTIOXIDANT EFFECTS OF NATURAL POLYPHENOLS IN EXPERIMENTAL DIABETES MELLITUS
M. Ciocoiu, D. Tutunaru, M. Badescu

35

AMAZONIAN FISHES DO NOT PROMOTE LEPTIN DNA GENOMIC (GDNA-LEP) ALTERATION IN THE OBESITY PHYSIOPATHOGENY
D. Coelho, R. Piccolotto, J. Monteiro, N. Garcia, F. Souza, R. Sales, E. Assuncao,

S. Astolfi-Filho, J. Souza, V. Silveira, L. Oyama, C. Nascimento, Brasil

36

AMAZONIC FISHES AS A PROMISING VEHICLE TO PREVENT THE DISLIPIDEMY, OBESITY AND HYPERTENSION
D. Coelho, R. Carvalho, J. Monteiro, N. Garcia, F. Souza, R. Sales, E. Assuncao,

S. Astolfi-Filho, J. Souza, V. Silveira, L. Oyama, C. Nascimento, Brasil

37

DIABETES OF THE LIVER: MOLECULAR MECHANISM OF HIGH FRUCTOSE CORN SYRUP-INDUCED LIVER DYSFUNCTION
K. Collison, S. Saleh, R. Bakheet, A. Inglis, R. Al-Rabiah, F. Al-Mohanna, Saudi Arabia

38

AN INNOVATIVE TOOL FOR TACKLING CHILDHOOD OBESITY
S. Darrow, K. Gupta, H. Dingman, C. Fernandez, USA

39

GLUCOSE ABNORMALITIES IN PATIENTS WITH ACUTE CORONARY HEART DISEASE: STUDY OF RELIABLE TOOLS IN CLINICAL PRACTICE
M. Del Olmo, J. Merino-Torres, P. Abellan, R. Camara, A. Perez-Lazaro, V. Campos, M. Navas, M. Argente, F.Buendía, F. Pinon-Selles, Spain

40

INSULIN RESISTANCE AND OTHER METABOLIC ABNORMALITIES IN ‘NORMAL WEIGHT OBESE’ TYPE 2 DIABETICS
N. Deshpande,N. Kapoor, S. Aman, R. Pilankar, R. Dhareshwar, India

41

ASSESSMENT AND CORRELATION OF DIABETES RELATED ASK (ATTITUDES, SKILLS, AND KNOWLEDGE) TO GLYCEMIC CONTROL IN A DIABETIC POPULATION
N. Deshpande, N. Kapoor, S. Aman, R. Pilankar, India

42

BODY FAT PERCENTAGE AND NORMAL WEIGHT OBESITY IN PATIENTS OF TYPE 2 DIABETES IN AN ASIAN POPULATION
N. Deshpande, N. Kapoor, S. Aman, R. Pilankar, India

43

FOOT ABNORMALITIES IN DIABETICS – PREVALENCE AND PREDICTORS IN AN ASIAN POPULATION
N. Deshpande, N. Kapoor, S. Aman, R. Pilankar, R. Dhareshwar, L. Dahiya, A. Jahagirdar, India

44

DIFFERENCES BETWEEN MEN AND WOMEN IN SEVERITY OF ESTABLISHED DIABETIC PERIPHERAL AND AUTONOMIC NEUROPATHY
T. Didangelos, F. Iliadis, A. Zantidis, C. Margaritidis, A. Chatzichidiroglou, D. Karamitsos, Greece

45

GAMMA-GLUTAMYLTRANSFERASE ACTIVITY AND GLYCAEMIC CONTROL IN NIDDM PATIENTS
O. Disoteo, V. Sedda, G. Pizzi, M. Parolini, J. Campolo, C. Dellanoce, R. Caruso,

M. Bianchi, R. De Maria, O. Parodi, Italy

46

ADEQUACY OF GLYCEMIC AND LIPID MANAGEMENT FOR PATIENTS WITH DIABETES IN PORTUGUESE HOSPITAL
S. Duarte, J. Conceição, H. Simões, L. Cortesão, I. Almeida, L. Elias, R. Matos,

M. Saraiva, Portugal

47

CYSTATIN C AND RENAL FUNCTION IN TYPE 2 DIABETIC PATIENTS. A 4 YEARS PROSPECTIVE STUDY
S. Duarte, V  Proenחa, L. Raposo, J. Costa, C. Vasconcelos, C. Limbert, A. Mendes,

R. Matos, M. Saraiva, Portugal

48

EFFECTS OF OLIVE OIL ON RISK FACTORS FOR ATHEROSCLEROSIS, NUTRITIONAL AND CALORIMETRICAL PARAMETERS IN OBESE RATS
G. Ebaid, F. Seiva, G. Souza, K. Rocha, E. Novelli, Brazil

49

SCREENING FOR UNDETECTED DIABETES IN KUWAIT AND EVALUATION OF NONINVASIVE RISK SCORES
M. Eid, M. Alkhalf, H. Najjar, K. Alhajry, L. Thalib, S. Doi, Kuwait

50

PLASMA APELIN AND ADMA LEVELS IN PATIENTS WITH ESSENTIAL HYPERTENSION
G. Erdem, G. Celebi, S. Tapan, H. Genc, C. Ercin, I. Tasci, T. Dogru, A. Sonmez, M. Kutlu, Turkey

51

CIRCULATING VON WILLEBRAND FACTOR LEVELS IN PATIENTS WITH PREDIABETES
G. Erdem,H. Genc, S. Tapan, C. Ercin, I. Tasci, T. Dogru, A. Sonmez, S. Erikci, M. Kutlu, Turkey

52

THE LEUCOCYTE AND PLATELET INDICES IN PATIENTS WITH IMPAIRED GLUCOSE TOLERANCE
G. Erdem, H. Genc, S. Tapan, C. Ercin, I. Tasci, T. Dogru, A. Sonmez, S. Erikci, M. Kutlu, Turkey

53

PREVALENCE OF HYPERTENSION AND ITS LIFESTYLE RELATED FACTORS AMONG MALE STAFF IN NATIONAL PETROCHEMICAL COMPANY , MAROON DISTRICT – IRAN
R. Eyvazi, M. Naderi, S. Dashti, E. Farabad, S. Shahmoradi, V. Hoseini, R. Amani, Iran

54

INSULIN DETEMIR REDUCES WEIGHT GAIN COMPARED WITH NPH AND INSULIN GLARGINE IN THE ZDF RAT – A MODEL OF TYPE 2 DIABETES
C. Fledelius,J. Damgaard, A. Vinterby, U. Ribel, J. Petersen, J. Sturis, Denmark

55

EVALUATION OF GINGIVAL FLUID MODIFICATIONS ON PATIENT AND ANIMAL GROUPS WITH PERIODONTAL ALTERATION, WITHIN DIABETES CONTEXT
L. Foia, V. Toma, D. Ungureanu, D. Forna, S. Nanescu, A. Indrei, Romania

56

THE CORRELATIONS BETWEEN ESSENTIAL HYPERTENSION AND VASCULAR INFLAMMATION :  THE ROLE OF BIOCHEMICAL MARKERS ADIPONECTINE, HIGH SENSITIVY-C-REACTIVE PROTEIN, F2-ISOPROSTANE AND NITRIC OXIDE
L. Gantini, A. Wijaya, S. Bakri, Indonesia

57

IS AN ORAL GLUCOSE TOLERANCE TEST NECESSARY FOR THE ASSESSMENT OF INSULIN RESISTANCE IN CHILDREN AND ADOLESCENTS?
S. Garnett,S. Srinivasan, S. Birt, G. Ambler, E. Lawrie, C. Cowell, M. Craig, Australia 

58

HEAT SHOCK PROTEIN 27 IS DOWN-REGULATED AND INCREASED MODIFIED BY METHYLGLYOXAL IN DIABETIC HEARTS
T. Gawlowski, B. Stratmann, I. Stork, R. Körfer, H. Milting, D. Tschoepe, Germany

59

COST EFFECTIVENESS OF A 2-STEP LIFESTYLE OR METFORMIN STRATEGY FOR PREVENTION OF TYPE 2 DIABETES
M. Gillett, N. Waugh, A. Brennan, G. Scotland, P. Royle, UK

60

PLASMA VISFATIN CONCENTRATIONS IN GESTATIONAL DIABETES MELLITUS
D. Gok, M. Yazici, G. Uckaya, S. Bolu, T. Ozgurtas, M. Kutlu, Turkey

61

RELIABILITY OF THE CLASSIFICATION OF NUTRITIONAL STATUS OBTAINED THROUGH THE BMI AND THREE DIFFERENT METHODS OF BODY FAT PERCENTAGE IN PATIENTS WITH TYPE 1 DIABETES MELLITUS
M. Gomes,R. Nunes, J. Pandini, S. Speradei, V. Dias, E. Clemente, Brazil

62

ANEMIA IN HOSPITALIZED DIABETIC PATIENTS: CLINICAL AND PROGNOSTIC SIGNIFICANCE
D. Almoznino-Sarafian, N. Cohen, M. Shteinshnaider, I. Tzur, A. Bar-Chaim, E. Iskhakov, D. Modai, O. Gorelik, Israel    

63

PREVALENCE OF OVERWEIGHT, OBESITY AND RELATED HEALTH RISK FACTORS AMONG MEDICAL WORKERS IN REPUBLIC OF SRPSKA
M. Grabez, A. Prtina, V. Rudic Grujic, B. Novakovic, Serbia

64

NEBIVOLOL INCREASES INSULIN SENSITIVITY AND VASCULAR ENOS EXPRESSION IN SPONTANEOUSLY HYPERTENSIVE RATS
M. Guarino, M. Mota-Carmo, A. Santos, P. Costa, A. Rendas, Portugal

65

IS HUMAN INSULIN THERAPY AS EFFICACIOUS AS INSULIN ANALOGS IN THE TREATMENT OF TYPE 1 DIABETES?
J. Guevara-Aguirre, M. Guevara-Aguirre, J. Saaverda, A. Rosenbloom, G. Bernstein, Canada 

66

IS SERUM FRUCTOSAMINE AN ADEQUATE MEASUREMENT FOR MONITORING LONG-TERM METABOLIC CONTROL IN TYPE 1 DIABETES?
J. Guevara-Aguirre, M. Guevara-Aguirre, J. Saaverda, A. Rosenbloom, G. Bernstein, Canada

67

HOW IMPORTANT ARE FEATURES OF ORAL ANTIDIABETIC AGENTS TO PEOPLE WITH TYPE 2 DIABETES?
A. Hauber, A. Mohamed, F. Johnson, H. Falvey, E. Snyder, USA

68

VISCERAL ADIPOSITY CAUSES DELAYED HYPERINSULINEMIA EVEN IN NON-OBESE SUBJECTS
M. Higa, M. Shimabukuro, Y. Shiohira, Japan

69

THE EFFECT OF WEIGHT LOSS ON SERUM MANNOSE BINDING LECTIN (MBL) LEVELS
P. Hoeyem, J. Bruun, S. Pedersen, B. Richelsen, J. Christiansen, T. Hansem, Denmark

70

CHANGE IN ARTERIAL STIFFNESS AMONG METABOLIC SYNDROME PATIENTS AFTER 10WEEKS OF AEROBIC EXERCISE
Y. Hwang, S. Song, J. Shin, S. Kang, Korea 

71

INFLUENCE OF CATECHIN AND EPICATECHIN ON OLEIC ACID FAT LOADED HEPG2 CELLS
M. Janevski, J. Antonas, P. Lewandowski, Australia

72

COMPARISON OF METABOLIC SYNDROME WITH GLUCOSE MEASUREMENT FOR PREDICTION OF TYPE 2 DIABETES: THE ISFAHAN DIABETES PREVENTION STUDY
M. Janghorbani, M. Amini, Iran

73

ARE OVERWEIGHT HYPERTENSIVE TYPE 2 DIABETIC PATIENTS MORE SALT-SENSITIVE OR NOT?
S. Jelic, Serbia

74

FOOT DEFORMATION & ITS RELATIONSHIP TO OBESITY, AND SOCIOECONOMICAL STATUS IN 8-12 YEARS CHILDREN IN SAUDI ARABIA
A. Jifri, E. Ali, Saudi Arabia

75

COST EFFECTIVENESS IN CONDUCTING COMMUNITY-BASED OBESITY CONTROL PROGRAM IN KOREA
N. Joo, Y. Park, G. Park, H. Chang, C. Kim, B. Kim, Korea

76

MODERATE WEIGHT REDUCTION IN OBESE TYPE 2 DIABETICS: EFFECT ON TOTAL, OXIDATIVE AND NONOXIDATIVE GLUCOSE DISPOSAL
A. Jotic,N. Lalic, K. Lalic, T. Milicic, L. Lukic, N. Rajkovic, M. Macesic, M. Zamaklar, Serbia

77

COMBINATION THERAPY FOR CONTROL OF DIABETES – DOES INSULIN THERAPY REALLY MATTER?
N. Kapoor, N. Deshpande, S. Aman, R. Pilankar, India

78

COMPARISON OF SERUM HIGH SENSITIVITY C – REACTIVE PROTEIN (HSCRP) LEVELS IN NORMAL WEIGHT OBESE INDIVIDUALS WITH  NON-OBESE INDIVIDUALS
N. Kapoor, N. Deshpande, S. Aman, R. Pilankar,  India

79

OBESITY AND ATHEROSCLEROTIC EVENTS IN CHRONIC  HEMODIALYSIS PATIENTS: A PROSPECTIVE STUDY
A. Kazory, K. Alexandre, C. Jean-Marc, D. Didier, France

80

COMPARATIVE STUDY OF INTERACTIONS OF ASPIRIN WITH OTHER DRUGS AS PREVENTION FOR CARDIOVASCULAR DISEASES IN DIABETES.
M. Kechagioglou, Italy

81

RAMADAN FASTING DIET INDUCES A LIPID METABOLISM DISORDER  IN TYPE 2 DIABETIC OBESE WOMEN
M. Khaled, S. Belbraouet, Canada

82

LIPID METABOLISM DISORDER IS THE RESULT OF RAMADAN-STYLE DIET PATTERN AMONG TYPE 2 DIABETIC OBESE WOMEN
M. Khaled, S. Belbraouet, Canada

83

PREDICTORS OF GLYCEMIC CONTROL IN A COHORT OF FAMILY PRACTICE PATIENTS
J. Kirk, G. Marion, S. Davis, E. Strachan, R. Lord, USA

84

ARTERIAL BARORECEPTOR CONTROL OF HEART RATE IN OBESE SUBJECTS DURING TILT TABLE TEST
J. Klawe, P. Zalewski, K. Buszko, M. Tafil-Klawe, P. Weber, Poland

85

DIAGNOSIS, RISK FACTORS AND PROGNOSTIC VALUE OF RENAL ARTERY STENOSIS IN TYPE 2 DIABETIC PATIENTS
I. Klefortova, M. Shamkhalova, O. Remizov, A. Bukhman, M. Shestakova, M. Sharia,

D. Ustyuzhanin, E. Tugeeva, U. Buziashvily, Russia

86

SOME ASPECTS OF MEDICO-SOCIAL PROBLEMS OF DISABILITY IN DIABETIC PERSONS
V. Krassimir, M. Vizeva, Bulgaria

87

COMPARISON OF LANCING DEVICES FOR SMBG REGARDING LANCING PAIN
S. Kocher, J. Tshiananga, R. Koubek, USA

88

GLYCEMIC CONTROL IS A MAJOR DETERMINANT OF ATHEROGENIC LIPOPROTEINS IN TYPE 2 DIABETES PATIENTS WITHOUT ABDOMINAL OBESITY: A CROSS-SECTIONAL STUDY
G. Koh,H. Chin, D. Lim, K. Park, Korea

89

IMPACT OF BLOOD-PRESSURE CONTROL ON DIABETIC NEPHROPATHY
IN HYPERTENSIVE TYPE 2 DIABETIC PATIENTS
I.A. Kyriazis, K. Korovesis, D. Mendrinos, A. Fortis , P. Bobolas, K. Laoumtzis, O. Bovoleti, A. Lalousis, E. Deda, G. Christodoulou,  A. Diakoumopoulos, K. Klimatsaki, Th. Kokolias,

I. Mallios, A. Manias, K. Barlas, C. Partheniou, A. Stavropoulos, Greece

90

IMPACT OF CIGARETTE SMOKING ON MACROVASCULAR COMPLICATIONS
IN TYPE 2 DIABETIC PATIENTS
I.A. Kyriazis, D. Mendrinos, D. Mytas, A.Manias, M. Bader, L. Georgali, A. Lalousis,

A. Koutsovasilis, A. Diakoumopoulos, G. Christodoulou A. Giolis, Z.Katsare, L. Bartzis,

N. Syrianos I. Mallios2, Th. Kokolias, Greece

91

IMPACT OF CIGARETTE SMOKING ON MICROVASCULAR COMPLICATIONS IN TYPE 2 DIABETIC PATIENTS
I.A. Kyriazis, D. Mendrinos, A. Koutsovasilis, A. Manias, P. Bobolas, O. Bovoleti, K. Zafeiri, K. Laoumtzis, G. Christodoulou, A. Diakoumopoulos, A. Lalousis, Z. Katsare, E. Deda,

N. Syrianos, E. Balatsou, P. Papapanos, K. Barlas, A. Stavropoulos, Greece

92

A COMPARISON OF COSTS AMONG PATIENTS WITH TYPE 2 DIABETES WHO INITIATED THERAPY WITH EXENATIDE OR INSULIN GLARGINE PLUS A SHORT-ACTING INSULIN
M. Lage, K. Secnik Boye, R. Fabunmi, D. Misurski, USA

93

CORONARY ARTERY DISEASE SEVERITY IN TYPE 2 DIABETES CORRELATES WITH LOWER INSULIN SENSITIVITY AND LDL PARTICLE SIZE
K. Lalic, M. Zamaklar, N. Lalic1, M. Ostojic, V. Kalimanovska, A. Topic, A. Jotic,

N. Rajkovic, L. Lukic, T. Milicic, Serbia

94

BODY MASS INDEX, LIPIDS, EMOTIONAL STATE AND QUALITY OF LIFE IN MALES AND FEMALES WITH DIABETES MELLITUS TYPE 2
L. Lasaite, J. Lasiene, Lithuanua

95

VASCULAR FACTORS IN MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE
J. Lee,J. Kim, C. Chung,  South Korea

96

EFFECT OF EXERCISE TRAINING ON A-FABP, LIPOCALIN-2, AND RBP4 LEVELS  SHORT TITLE: EXERCISE EFFECT ON LIPOCALIN FAMILY
M. Lee, Korea

97

LIPID PROFILE AT NEWLY DIAGNOSED T1DM AND T2DM, COHORT 2007
D. Licaroiu, E. Ungurasu, C. Ionescu-Tirgoviste, T. Constantin, Romania

98

CHRONIC COMPLICATIONS AT NEWLY DIAGNOSED T1DM AND T2DM, COHORT 2007
D. Licaroiu,E. Ungurasu, C. Ionescu-Tirgoviste, Romania

99

INSULIN DETEMIR PLUS REPAGLINIDE AND METFORMIN IMPROVES GLYCAEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES
A. Liebl, Germany

100

CROSSTALK BETWEEN MITOCHONDRIAL DYSFUNCTION AND ENDOPLASMIC RETICULUM STRESS IN HEPATIC INSULIN RESISTANCE
J. Lim, H. Lee, M. Jung, J. Song, South Korea

101

EXENETIDE: IS IT BENEFICIAL FOR INSULIN TREATED TYPE 2 DIABETICS (T2DM)?
S. Hulme, S. Keigan, UK

102

EFFECTS OF A SINGLE SESSION OF SUBMAXIMAL EXERCISE ON ATHEROGENIC LIPIDS IN UNTREATED MILD HYPERTENSIVE PATIENTS
Z. Caparevic,N. Kostic, S. Ilic, L. Konstantinovic, S. Jelic, Serbia

103

THE EFFECT OF LIPID LOWERING THERAPY ON HS-CRP AND OXLDL IN TYPE 2 DIABETES MENOPAUSAL WOMEN
Z. Caparevic, N. Kostic, J. Radojkovic, S. Ilic,  M. Dekleva, B. Pencic, V. Celic, Serbia

104

RISK FACTORS AND PROGNOSTIC VALUE OF CONTRAST-INDUCED NEPHROPATHY IN PATIENTS WITH DIABETES MELLITUS TYPE 2
N. Zaytseva,M. Shamkhalova, M. Shestakova, S. Matskeplishvili, E. Tugeeva, U. Buziashvili, A. Deev, Russia

105

IS THE MANCHESTER TRIAGE SYSTEM, AN ADEQUATE SCREENING METHOD FOR ACUTE MYOCARDIAL INFARCTION IN DIABETIC PATIENTS?
P. Lourenço Gomes,R. Providencia, A. Antunes, S. Barra, A. Leitão Marques, Portugal

106

HYPERLEPTINEMIA MAY BE INVOLVED IN THE DEVELOPMENT OF POST-TRANSPLANT DIABETES  IN KIDNEY TRANSPLANT RECIPIENTS
A. Kagan,R. Sarafian, N. Haran, J. Rapoport, Israel

107

BENEFICIAL EFFECTS OF ARBS TREATMENT IN TYPE 2 DIABETICS WITH ACE ESCAPE
N. Trubitsyna, M. Shamkhalova, M. Shestakova, Russia

EVALUATION OF THE RELATIONSHIP BETWEEN SEX HORMONE LEVELS AND BONE MINERAL DENSITY IN MEN WITH TYPE 1 DIABETES

E. Enchev

THE RELATIONSHIP BETWEEN SEX HORMONE LEVELS AND BONE MINERAL DENSITY IN INSULIN TREATED MEN WITH TYPE 2 DIABETES

E. Enchev